Table of Contents
<< Previous Issue | Aug 2016 (Vol: 2016, Issue: 8) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Galenica Acquires Relypsa to Bolster Its Cardio-Renal Portfolio
-
Pfizer Boosts Rare Disease Franchise through Bamboo Therapeutics Acquisition
-
Pfizer Significantly Increases Oncology Presence with Medivation Acquisition
- Section: Research & Development
-
Celgene Welcomes Jounce to its Immuno-Oncology Collaborators List with US$2.56 B Deal
-
Amgen Shows Confidence in Advaxis’ Platform with $540 M Deal